Skip to content
Application 208746
- Type
- NDA
- Sponsor
- HOSPIRA INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PEMETREXED | PEMETREXED | POWDER;INTRAVENOUS | EQ 100MG BASE/VIAL | No | No |
| 002 | PEMETREXED | PEMETREXED | POWDER;INTRAVENOUS | EQ 500MG BASE/VIAL | No | No |
| 003 | PEMETREXED | PEMETREXED | POWDER;INTRAVENOUS | EQ 1G BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0409-1060 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1060 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1060 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1060 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1061 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1061 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1061 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1061 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1062 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1062 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
| 0409-1062 | Pemetrexed | Pemetrexed | Hospira, Inc. | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 73084 | ORIG | 2023-01-04 |
| 71286 | ORIG | 2022-06-13 |
| 71271 | ORIG | 2022-06-13 |
| 65892 | ORIG | 2021-01-12 |